HR-2592-119
Ordered to be Reported (Amended) by Voice Vote.
Sponsored by Sean Casten (D-IL)
What it does
This bill would require the FAA Administrator to publish and maintain a public website listing medications and treatments considered safe for pilots seeking medical certification, including a "Do Not Issue" list of prohibited medications. The list must be developed with input from pilot and air traffic controller unions and other stakeholders, updated annually, and include information on stabilization periods, contact mechanisms for medical providers, and explanations for medication decisions.
Who benefits
Pilots and student pilots seeking medical certification, who would gain clearer information about which medications are compatible with flying; aviation medical examiners and treating physicians who currently face uncertainty about FAA medication policies; airline and general aviation safety advocates; and pharmaceutical guidance organizations like the Aeromedical Innovation and Modernization Working Group and pilot unions involved in drafting the list.
Who is hurt
No group bears a significant direct cost, though the FAA would incur administrative and staffing burdens to compile, publish, and annually update the list, and pilots who currently avoid disclosing medication use due to ambiguous rules could face clearer disqualification from certification once medications are explicitly listed as "Do Not Issue."
Supporters argue
Supporters argue that pilots and doctors currently navigate an opaque, informal FAA medication approval process, leading some pilots to avoid necessary treatment or fail to disclose medication use for fear of losing certification, which can create safety risks. They contend that a clear, public, regularly updated list developed with input from pilot unions and medical experts would improve both aviation safety and pilot access to needed medical care.
Opponents argue
Opponents argue that publishing a rigid public list could oversimplify complex, case-by-case medical determinations and create pressure on the FAA to treat the list as exhaustive rather than illustrative, potentially disqualifying pilots whose specific circumstances warrant exceptions. They contend that mandating stakeholder consultation and annual updates adds administrative burden and rulemaking rigidity without a clear funding mechanism to support the added work.
Constitutional context
This bill involves Congress directing an executive agency's administrative and disclosure functions under its Article I, Section 8 authority to regulate interstate air commerce; it does not implicate major questions doctrine concerns since it directs transparency rather than new substantive regulatory authority.
Checks and balances
Congress directs the FAA (an executive agency) to create and publish a specific administrative product, with no new independent rulemaking authority granted beyond existing certification standards.
Historical precedent
The FAA has long maintained informal internal guidance on approved medications for airman certification, but this bill would be the first statutory mandate requiring a formal, public, regularly updated list.